News and Trends 9 Jan 2023Selecta and Astellas sign LOPD treatment agreement Selecta Biosciences, Inc. and Astellas Pharma Inc. have announced an exclusive licensing and development agreement for IdeXork (Xork). Xork is… January 9, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Aug 2022Aro Biotherapeutics gets FDA orphan drug designation for treatment of Pompe Disease Aro Biotherapeutics says the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ABX1100, an investigational Centyrin-siRNA… August 10, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2022Trial for adults with late onset Pompe disease halted due to serious adverse event The US Food and Drug Administration (FDA) has placed a clinical hold on a trial being run for Astrellas Pharma… June 27, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email